Codexis (CDXS) Receivables (2010 - 2026)
Codexis (CDXS) posted quarterly Receivables of $9.3 million for Q1 2026, down 39.62% year-over-year from $15.4 million in Q1 2025, and down 23.39% quarter-over-quarter from $12.2 million in Q4 2025.
Codexis (CDXS) Receivables (2010 - 2026) Analysis & Trends
Codexis' Receivables history runs 17 years deep, the most recent figure standing at $9.3 million for Q1 2026.
- In Q1 2026, Receivables fell 39.62% year-over-year to $9.3 million; the TTM figure through Mar 2026 stood at $9.3 million (down 39.62% YoY), while the FY2025 annual figure was $12.4 million, down 43.75% from the prior year.
- Receivables for Q1 2026 stood at $9.3 million, down from $12.2 million in the prior quarter.
- The five-year high for Receivables was $57.5 million in Q2 2022, with the low at $9.3 million in Q1 2026.
- The 5-year median for Receivables is $19.5 million (2023), against an average of $22.7 million.
- The sharpest annual moves came in 2022 and 2023: Receivables jumped 80.11% in 2022, then slumped 66.07% in 2023.
- Codexis' Receivables stood at $38.9 million in 2022, then retreated by 23.35% to $29.8 million in 2023, then dropped by 25.95% to $22.1 million in 2024, then slumped by 44.93% to $12.2 million in 2025, then slipped by 23.39% to $9.3 million in 2026.
- Business Quant data shows CDXS's Receivables at $9.3 million in Q1 2026, $12.2 million in Q4 2025, and $11.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.92 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.57 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 59.12 Bn | 53.98 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.75 Bn | 28.45 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.72 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.20 Bn | 26.36 Bn | - | - |
| 10 | Codexis | 145.68 Mn | 90.77 Mn | 11.40 Mn | 13.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.03 Mn |
| Mar 31, 2026 | 9.32 Mn |
| Dec 31, 2025 | 12.17 Mn |
| Sep 30, 2025 | 11.73 Mn |
| Jun 30, 2025 | 15.59 Mn |
| Mar 31, 2025 | 15.44 Mn |
| Dec 31, 2024 | 22.09 Mn |
| Sep 30, 2024 | 21.33 Mn |
| Jun 30, 2024 | 17.93 Mn |
| Mar 31, 2024 | 12.61 Mn |
| Dec 31, 2023 | 29.83 Mn |
| Sep 30, 2023 | 24.75 Mn |
| Jun 30, 2023 | 19.50 Mn |
| Mar 31, 2023 | 17.73 Mn |
| Dec 31, 2022 | 38.92 Mn |
| Sep 30, 2022 | 24.02 Mn |
| Jun 30, 2022 | 57.46 Mn |
| Mar 31, 2022 | 34.78 Mn |
| Dec 31, 2021 | 46.21 Mn |
| Sep 30, 2021 | 35.84 Mn |